WS #10752
ACADIA Pharmaceuticals receives positive EU CHMP opinion for DAYBU in Rett syndrome, and Incyte gets positive CHMP opinion for Opzelura cream, driving biotech sector interest.
Positive Biotech Catalysts
ACADIA Pharmaceuticals receives positive EU CHMP opinion for DAYBU in Rett syndrome, and Incyte gets positive CHMP opinion for Opzelura cream, driving biotech sector interest.